Academic Bibliography

Show Sort by

Your filters: cql: subject exact "Medicine and Health Sciences" cql: author exact 001960665444 or (type exact bookEditor and editor exact 001960665444)

Mark
- conference
- C3
- open access
Pre-clinical pharmacokinetics of selected quorum sensing peptides

Yorick Janssens (UGent) , Evelien Wynendaele (UGent) , Frederick Verbeke (UGent) and Bart De Spiegeleer (UGent)

(2016) European Peptide symposium, 34th, Abstracts.
Mark
Human skin permeation of emerging mycotoxins (beauvericin and enniatins)

Lien Taevernier (UGent) , Lieselotte Veryser (UGent) , Nathalie Roche (UGent) , Kathelijne Peremans (UGent) , Christian Burvenich (UGent) , Catherine Delesalle (UGent) and Bart De Spiegeleer (UGent)

(2016) JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY. 26(3). p.277-287
Mark
- conference
- C3
- open access
Do cyclic depsipeptide mycotoxins beauvericin and enniatins cross the blood-brain barrier?

Lien Taevernier (UGent) , Nathalie Bracke (UGent) , Lieselotte Veryser (UGent) , Evelien Wynendaele (UGent) and Bart De Spiegeleer (UGent)

(2016)
Mark
Pharmaceutical regulatory framework in Ethiopia : a critical evaluation of its legal basis and implementation

Sultan Suleman Wega (UGent) , Abdulkadir Woliyi, Kifle Woldemichael , Kora Tushune , Luc Duchateau (UGent) , Agnes Degroote, Roy Vancauwenberghe, Nathalie Bracke (UGent) and Bart De Spiegeleer (UGent)

(2016) ETHIOPIAN JOURNAL OF HEALTH SCIENCES. 26(3). p.259-276
Mark
- conference
- C3
- open access
Bacterial quorum sensing peptides and the inter-kingdom communication with human cancer cells

Frederick Verbeke (UGent) , Evelien Wynendaele (UGent) , Yorick Janssens (UGent) and Bart De Spiegeleer (UGent)

(2016)
Mark
Quality control of cationic cell-penetrating peptides

Sofie Stalmans (UGent) , Bert Gevaert (UGent) , Frederick Verbeke (UGent) , Matthias D'Hondt, Nathalie Bracke (UGent) , Evelien Wynendaele (UGent) and Bart De Spiegeleer (UGent)

(2016) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 117. p.289-297
Mark
Regulatory development of geriatric medicines : to GIP or not to GIP?

Bart De Spiegeleer (UGent) , Evelien Wynendaele (UGent) , Nathalie Bracke (UGent) , Lieselotte Veryser (UGent) , Lien Taevernier (UGent) , Agnes Degroote and Sofie Stalmans (UGent)

(2016) AGEING RESEARCH REVIEWS. 27. p.23-36
Mark
- journalArticle
- A2
- open access
Characterization data on the topical carrier DDC642

Eline Desmet (UGent) , STEFANIE BRACKE (UGent) , Katrien Forier (UGent) , Lien Taevernier (UGent) , Marc CA Stuart, Bart De Spiegeleer (UGent) , Koen Raemdonck (UGent) , Mireille Van Gele (UGent) and Jo Lambert (UGent)

(2016) DATA IN BRIEF. 7. p.1204-1210
Mark
- conference
- C3
- open access
The effects of quorum sensing peptides on colon cancer cells: implications for the role of the gut microbiome

Yorick Janssens (UGent) , Evelien Wynendaele (UGent) , Frederick Verbeke (UGent) , An Hendrix (UGent) , Olivier De Wever (UGent) , Marc Bracke (UGent) and Bart De Spiegeleer (UGent)

(2016) OncoPoint, 4th Research seminar, Abstracts.
Mark
An analytical quality by design (aQbD) approach for a L-asparaginaseactivity method

Han Yao (UGent) , Jochem Vancoillie, Matthias D'Hondt, Evelien Wynendaele (UGent) , Nathalie Bracke (UGent) and Bart De Spiegeleer (UGent)

(2016) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 117. p.232-239

← Previous

Academic Bibliography

Pre-clinical pharmacokinetics of selected quorum sensing peptides

Human skin permeation of emerging mycotoxins (beauvericin and enniatins)

Do cyclic depsipeptide mycotoxins beauvericin and enniatins cross the blood-brain barrier?

Pharmaceutical regulatory framework in Ethiopia : a critical evaluation of its legal basis and implementation

Bacterial quorum sensing peptides and the inter-kingdom communication with human cancer cells

Quality control of cationic cell-penetrating peptides

Regulatory development of geriatric medicines : to GIP or not to GIP?

Characterization data on the topical carrier DDC642

The effects of quorum sensing peptides on colon cancer cells: implications for the role of the gut microbiome

An analytical quality by design (aQbD) approach for a L-asparaginaseactivity method

Contents

Support

Contact